Phenotype Summary

Phenotypes

Publication	Data		Phenotype
Mathews et al., 2016	Fig. 1		oligodendrocyte MAPK cascade decreased occurrence, abnormal oligodendrocyte TOR signaling decreased occurrence, abnormal oligodendrocyte TOR signaling occurrence, ameliorated spinal cord oligodendrocyte ab1-rps6 labeling amount, ameliorated spinal cord oligodendrocyte ab1-rps6 labeling decreased amount, abnormal spinal cord oligodendrocyte ab20-mapk labeling decreased amount, abnormal
Mathews et al., 2014	Fig. 1		dorsal longitudinal fasciculus morphology, normal medial longitudinal fasciculus morphology, normal oligodendrocyte mislocalised dorsally, abnormal spinal cord has fewer parts of type spinal cord oligodendrocyte, abnormal spinal cord has normal numbers of parts of type spinal cord oligodendrocyte, normal spinal cord oligodendrocyte dorsal to dorsal longitudinal fasciculus, abnormal spinal cord oligodendrocyte mislocalised dorsally, abnormal ventral spinal nerve morphology, normal
	Fig. 4		oligodendrocyte development process quality, abnormal oligodendrocyte mislocalised dorsally, abnormal spinal cord oligodendrocyte far from dorsal longitudinal fasciculus, abnormal
	Fig. 5		oligodendrocyte development process quality, abnormal spinal cord central nervous system myelination process quality, normal spinal cord oligodendrocyte adjacent to dorsal longitudinal fasciculus, normal spinal cord oligodendrocyte dorsal to dorsal longitudinal fasciculus, abnormal spinal cord oligodendrocyte mislocalised dorsally, abnormal spinal cord oligodendrocyte position, normal
	Fig. 7		oligodendrocyte development process quality, abnormal spinal cord oligodendrocyte dorsal to dorsal longitudinal fasciculus, abnormal spinal cord oligodendrocyte mislocalised dorsally, abnormal